Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Palatin Technologies Inc (PTN)

NYSE
Symbol
Exchange
Currency
PTNNYSEUSD
0KF3LondonUSD
Currency in USD
Disclaimer
1.7200
-0.0100(-0.58%)
Closed
Pre Market
1.72000.0000(0.00%)

PTN Comments

Wow.... $3 target price.... It's 200% return....
Between $2 & $3  : https://www.tipranks.com/stocks/ptn/forecast
This isGoing to 3$ minimum!
hi Private Banker, you noted gonna to $3 min based on reports, your research, thanks as I'm thinking of investing in this stock
Wow...target?
0.7
3
Rocket started engine... go go go...
very good company... certainly good to keep for long term
Fly now,✔️✔️✔️
buy buy..if breaks 0.485 🚀🚀🚀🚀
Sleeping Beauty!!!
Beauty 👎 😡I lose 40% from 0.61
poia einai i apopsi sas Kyrie Philippe gia tHn Pfizer ?
you only lose if you sell
28 US dollar is the fair value for the company
My valuation tool says that, as well lol :D not that much really, but considering how they are creating value from cash and good drugs in pipe, 2-3$ easily in a few years.
I think the turn is v. near for PTN.. I started with TNXP @ this level ... sold and bought PTN??
On fire right now.
Should i get in now?
🚀🚀🚀
I like $HTBX because its stock price is up by more than 500% since March when the medical research firm announced COVID-19-related developments. I like $PTN because they said it would test one of its investigational drugs as a treatment for COVID-19. The PTN plans to submit an investigational new drug application in the third quarter of the year and initiate a Phase 2 randomized, controlled clinical trial for hospitalized adult COVID-19 patients with hypoxemic respiratory failure in the fourth quarter. $HTBX is 2.90 a share and $PTN is .53 cents a share with a STRONG BUY rating and target of 3.00.
PE under 5 still, ROIC% and ROE support profitable growth over cost of capital. They have a new drug licensed with Amag pharmaceuticals. I don't understand why this hasn't taken off already big time. Nasdaq analysts estimate 2,5$ fair price, simply wall street a whopping 24$ (yea, that's too much) but still...
doess anyone knows what is going on with Palating
Next earnings seems to be neutral, not bullish nor bearish hopefully we get a surprise
Earnings report tomorrow, my guess is the price will not move too much
when AMAG give $60 million
The money was given 2 weeks ago and has already been factored into the price which is why we aren't at $0.77 anymore
Update: the $60 million from AMAG to PTN takes 30 business days so maybe the first week of August
PTN has got a $60 million dollar bonus coming tomorrow, hopefully it can go over 1.51 so I can get the he k out.
yep it was up a few days ago I'm going to hold for a few weeks. My AI predicted a 90% up swing within the next few weeks. we will see!
Hope you're AI is right, I read the news about AMAG ”possible” buyout”, maybe PTN is involved somehow
need a come back and then some
why is this falling off a cliff ???
because some dude said it wouldn't get the customer base it needs to be profitable for the company or AMAG.
why is this falling off a cliff ???
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.